601 Drugs Pass Formal Review for 2026 Medical Insurance Catalogue Adjustment

Regulation
โดย Jiemian·Read original
Summary · why it matters

The National Healthcare Security Administration today released the list of drugs that have passed the formal review for the 2026 adjustment of the National Basic Medical Insurance, Maternity Insurance, and Work-Related Injury Insurance Drug Catalogue, as well as the Commercial Health Insurance Innovative Drug Catalogue. During the application phase for the 2026 catalogue adjustment, the National Healthcare Security Administration received a total of 800 applications for the basic medical insurance catalogue, covering 614 generic drug names, with 348 applications for drugs outside the catalogue and 266 for drugs already in the catalogue. For the commercial health insurance innovative drug catalogue, 91 applications were received, covering 62 generic drug names, with 58 applications for drugs outside the catalogue and 4 for drugs already in the catalogue.

Impact on stocks 1

Others · 1 stocks